advertisement
Harada T 19
Showing records 1 to 19 | Display all abstracts from Harada T117274 Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
Shinozaki Y
Frontiers in ophthalmology 2023; 3: 1310226
118175 Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
Wang Y
NeuroMolecular Medicine 2024; 26: 13
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Namekata K
Journal of Pharmacological Sciences 2024; 154: 326-333
117274 Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
Namekata K
Frontiers in ophthalmology 2023; 3: 1310226
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Noro T
Journal of Pharmacological Sciences 2024; 154: 326-333
118175 Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
Brahma MM
NeuroMolecular Medicine 2024; 26: 13
117274 Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
Guo X
Frontiers in ophthalmology 2023; 3: 1310226
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Nishijima E
Journal of Pharmacological Sciences 2024; 154: 326-333
118175 Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
Takahashi K
NeuroMolecular Medicine 2024; 26: 13
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Sotozono A
Journal of Pharmacological Sciences 2024; 154: 326-333
117274 Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
Harada T
Frontiers in ophthalmology 2023; 3: 1310226
118175 Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
Hernandez ANB
NeuroMolecular Medicine 2024; 26: 13
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Guo X
Journal of Pharmacological Sciences 2024; 154: 326-333
118175 Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
Ichikawa K; Minami S
NeuroMolecular Medicine 2024; 26: 13
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Harada C; Shinozaki Y
Journal of Pharmacological Sciences 2024; 154: 326-333
118175 Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
Goshima Y
NeuroMolecular Medicine 2024; 26: 13
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Mitamura Y
Journal of Pharmacological Sciences 2024; 154: 326-333
118175 Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
Harada T; Ohshima T
NeuroMolecular Medicine 2024; 26: 13
118469 Drug combination of topical ripasudil and brimonidine enhances neuroprotection in a mouse model of optic nerve injury
Nakano T; Harada T
Journal of Pharmacological Sciences 2024; 154: 326-333
